Refresh

Lyons Corporate Market Ltd.

Price on BSE   27 Sep,09:48 LIVE
6.43
+1.07
(+19.96%)

© 2024 Rediff.com
  • Volume :
  • 300.00
  • Prev Close :
  • 5.36
  • Day's H/L (Rs.) :
  • 6.43 - 6.43
  • 52wk H/L (Rs.) :
  • 5.36 - 4.87
  • Mkt Cap (Rs. Cr) :
  • 3.03
Lyons Corporate Market Ltd. is not listed on NSE

© 2024 Rediff.com
Report Card - Lyons Corporate Market Ltd.
PE Ratios
-138.62
EPS (Rs.)
-0.05
Sales (Rs. Cr)
0.22
Face Value (Rs.)
10
Net Profit Margin(%)
11.00
Last Bonus
-
Last Dividend(%)
-
Return on Average Equity
0.75

News for Finance

Dr Reddy's Licenses Gilead's HIV Drug Lenacapavir
Dr Reddy's Laboratories has partnered with Gilead Sciences to manufacture and commercialize the HIV drug Lenacapavir in India and 120 other countries. The drug is indicated for treatment of...
Oct 02, 2024 19:52
Indian Businesses Eye UK Expansion: Report
A new report reveals the UK is a top choice for Indian businesses looking to expand internationally. An India-UK free trade agreement is expected to further boost this trend.
Oct 02, 2024 19:50
Lava Agni 3: Smartphone with Rear Display Launching Oct 4
Lava to launch Agni 3 smartphone series with a rear display on October 4. This innovative phone features a rear display for calls, messages, and selfies using the main camera.
Oct 02, 2024 19:40
Hetero & Gilead Partner for HIV Drug Lenacapavir Access
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and middle-income countries. This partnership aims to improve treatment options and...
Oct 02, 2024 19:23
Tesla Q3 Deliveries Rise: Price Cuts, Financing Boost Sales
Tesla's global deliveries increased in Q3, driven by price cuts, financing deals, and free charging. The company delivered 462,890 vehicles, exceeding analyst estimates.
Oct 02, 2024 19:22

More News »

Top News

Dr Reddy's Licenses Gilead's HIV Drug Lenacapavir
Dr Reddy's Laboratories has partnered with Gilead Sciences to manufacture and commercialize the HIV drug Lenacapavir in India and 120 other countries. The drug is indicated for treatment of...
Oct 02, 2024 19:52
Indian Businesses Eye UK Expansion: Report
A new report reveals the UK is a top choice for Indian businesses looking to expand internationally. An India-UK free trade agreement is expected to further boost this trend.
Oct 02, 2024 19:50
Lava Agni 3: Smartphone with Rear Display Launching Oct 4
Lava to launch Agni 3 smartphone series with a rear display on October 4. This innovative phone features a rear display for calls, messages, and selfies using the main camera.
Oct 02, 2024 19:40
Hetero & Gilead Partner for HIV Drug Lenacapavir Access
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and middle-income countries. This partnership aims to improve treatment options and...
Oct 02, 2024 19:23
Tesla Q3 Deliveries Rise: Price Cuts, Financing Boost Sales
Tesla's global deliveries increased in Q3, driven by price cuts, financing deals, and free charging. The company delivered 462,890 vehicles, exceeding analyst estimates.
Oct 02, 2024 19:22

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com